Immunoreactivity to Cetuximab in Cancer Patients
Clinical trial NCT00896896 · COMPLETED
Trial details
- NCT number
- NCT00896896
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-10-01
- Enrollment
- 538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.